We are all different in unique ways, yet modern treatments ignore an individual’s genetic variation.
By combining our biological expertise and capabilities and our engineering background, Bi/ond aims at improving medical treatment of millions of patients by providing innovative hardware solutions for enabling biomedical research, which reflects our natural diversity. With such an objective in mind, this biotechnology startup provides tools to some of the top European hospitals and collaborates with a myriad of technical institutes and research centers to help them advance in their biotech research.
Bi/ond is also committed to the 3Rs – replace, reduce, refine – guiding principles of animal use in science. Through the use of our technology, we also empower organizations with valid alternatives to the use of animals in testing, aiming for a future where animal free research is a reality.
The microchips built by Bi/ond recreate key aspects of human organs, such as the beating of a heart, tissue interactions and blood circulation.
Our products are designed to aid researchers and scientists in their studies and to assist pharmaceutical and biotech companies (either directly or through CROs) in drug discovery and development.
Cutting-edge cell environments for biologists that demand nothing less than the best from our product and our team.
inCHIPit™
MUSbit™
We develop a versatile organ-on-chip platform meant for complex 3D tissue (organoids, ex vivo tissue, spheroids, microtissues) cultivation as well as tissue-tissue interface models.
The MUSbit™, in combination with the comPLATE™, presents a revolutionary solution for culturing mature, contractile muscle tissue. This system not only offers the capability to study the functioning of (heart) muscle tissue, but also provides a platform for testing the efficacy of new drugs, thanks to the microfluidic channel
Supporting biomedical research and industry leaders
Bi/ond protects your privacy: when you request a quote, documentation or price options your personal data will be transferred to the Bi/ond team who will be able to contact you directly. See our Privacy Policy for details on the method used to process your data, the purpose and your rights concerning this data. By continuing to use our website you agree to our General Terms of Use.